South Dakota Court Revives Cymbalta Suicide Case


A federal appeals court has reversed a lower court’s summary judgment in favor of Eli Lilly,   allowing the parents of a South Dakota teenager who committed suicide while taking the antidepressant Cymbalta to sue the drug’s makers for failure to warn and deceit. The prescribing doctor did not know that there was an FDA “black box” warning on the drug, informing about the increased risk of suicidality in children and teens. The Cymbalta samples given to the doctor had been removed from their packaging and contained no warning information.

Article → 

Previous articleNIH Defends Nemeroff Grant, Issues Talking Points
Next articleKirsch’s Antidepressant/Placebo Calculations “are Correct”
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].